151 related articles for article (PubMed ID: 9817307)
1. Endopyelotomy failure is associated with reduced transforming growth factor-beta.
Jabbour ME; Goldfischer ER; Anderson AE; Smith AD; Kushner L
J Urol; 1998 Dec; 160(6 Pt 1):1991-4. PubMed ID: 9817307
[TBL] [Abstract][Full Text] [Related]
2. Failed endopyelotomy: low expression of TGF beta regardless of the presence or absence of crossing vessels.
Jabbour ME; Goldfischer ER; Anderson AE; Kushner L; Smith AD
J Endourol; 1999 May; 13(4):295-8. PubMed ID: 10405909
[TBL] [Abstract][Full Text] [Related]
3. Endopyelotomy failure is associated with reduced urinary transforming growth factor-beta1 levels in patients with upper urinary tract obstruction.
Liatsikos EN; Dinlenc CZ; Bernardo NO; Kapoor R; Jabbour ME; Smith AD; Kushner L
J Endourol; 2001 Aug; 15(6):567-70. PubMed ID: 11552777
[TBL] [Abstract][Full Text] [Related]
4. Comparison of percutaneous endopyelotomy with open pyeloplasty for pediatric ureteropelvic junction obstruction.
Schenkman EM; Tarry WF
J Urol; 1998 Mar; 159(3):1013-5. PubMed ID: 9474220
[TBL] [Abstract][Full Text] [Related]
5. Potential role for the nuclear transcription factor NF-kappa B in the pathogenesis of ureteropelvic junction obstruction.
Ruiz-Deya G; Sikka SC; Thomas R; Abdel-Mageed AB
J Endourol; 2002 Oct; 16(8):611-5. PubMed ID: 12470471
[TBL] [Abstract][Full Text] [Related]
6. Cost Analysis of Treatments for Ureteropelvic Junction Obstruction.
Jacobs BL; Seelam R; Lai JC; Hanley JM; Wolf JS; Hollenbeck BK; Hollingsworth JM; Dick AW; Setodji CM; Saigal CS
J Endourol; 2017 Feb; 31(2):204-209. PubMed ID: 27927021
[TBL] [Abstract][Full Text] [Related]
7. Endopyelotomy for primary ureteropelvic junction obstruction: risk factors determine the success rate.
Danuser H; Ackermann DK; Böhlen D; Studer UE
J Urol; 1998 Jan; 159(1):56-61. PubMed ID: 9400436
[TBL] [Abstract][Full Text] [Related]
8. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction.
Kajbafzadeh AM; Payabvash S; Salmasi AH; Monajemzadeh M; Tavangar SM
J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927
[TBL] [Abstract][Full Text] [Related]
9. Endopyelotomy for primary repair of ureteropelvic junction obstruction.
Brannen GE; Bush WH; Lewis GP
J Urol; 1988 Jan; 139(1):29-32. PubMed ID: 3336099
[TBL] [Abstract][Full Text] [Related]
10. The expression of epidermal growth factor and transforming growth factor-beta1 in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children.
Yang Y; Zhou X; Gao H; Ji SJ; Wang C
J Pediatr Surg; 2003 Nov; 38(11):1656-60. PubMed ID: 14614718
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Endopyelotomy over High Pressure Balloon for Recurrent Ureteropelvic Junction Obstruction in Children.
Parente A; Angulo JM; Burgos L; Romero RM; Rivas S; Ortiz R
J Urol; 2015 Jul; 194(1):184-9. PubMed ID: 25623746
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction.
Sundaram CP; Grubb RL; Rehman J; Yan Y; Chen C; Landman J; McDougall EM; Clayman RV
J Urol; 2003 Jun; 169(6):2037-40. PubMed ID: 12771713
[TBL] [Abstract][Full Text] [Related]
13. Variation in the Use of Open Pyeloplasty, Minimally Invasive Pyeloplasty, and Endopyelotomy for the Treatment of Ureteropelvic Junction Obstruction in Adults.
Jacobs BL; Lai JC; Seelam R; Hanley JM; Wolf JS; Hollenbeck BK; Hollingsworth JM; Dick AW; Setodji CM; Saigal CS
J Endourol; 2017 Feb; 31(2):210-215. PubMed ID: 27936909
[TBL] [Abstract][Full Text] [Related]
14. Pediatric endopyelotomy: the Washington University experience.
Figenshau RS; Clayman RV; Colberg JW; Coplen DE; Soble JJ; Manley CB
J Urol; 1996 Dec; 156(6):2025-30. PubMed ID: 8911382
[TBL] [Abstract][Full Text] [Related]
15. The Comparative Effectiveness of Treatments for Ureteropelvic Junction Obstruction.
Jacobs BL; Lai JC; Seelam R; Hanley JM; Wolf JS; Hollenbeck BK; Hollingsworth JM; Dick AW; Setodji CM; Saigal CS;
Urology; 2018 Jan; 111():72-77. PubMed ID: 28943371
[TBL] [Abstract][Full Text] [Related]
16. Endopyelotomy for secondary ureteropelvic junction obstruction in children.
Kavoussi LR; Meretyk S; Dierks SM; Bigg SW; Gup DI; Manley CB; Shapiro E; Clayman RV
J Urol; 1991 Feb; 145(2):345-9. PubMed ID: 1988728
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous endopyelotomy in the treatment of ureteropelvic junction obstruction.
Lojanapiwat B; Lertsupphakul B
J Med Assoc Thai; 2004 Aug; 87(8):947-50. PubMed ID: 15471300
[TBL] [Abstract][Full Text] [Related]
18. Adult endopyelotomy: impact of etiology and antegrade versus retrograde approach on outcome.
Shalhav AL; Giusti G; Elbahnasy AM; Hoenig DM; McDougall EM; Smith DS; Maxwell KL; Clayman RV
J Urol; 1998 Sep; 160(3 Pt 1):685-9. PubMed ID: 9720521
[TBL] [Abstract][Full Text] [Related]
19. Endopyelotomy for pediatric ureteropelvic junction obstruction: a review of our 25-year experience.
Kim EH; Tanagho YS; Traxel EJ; Austin PF; Figenshau RS; Coplen DE
J Urol; 2012 Oct; 188(4 Suppl):1628-33. PubMed ID: 22906656
[TBL] [Abstract][Full Text] [Related]
20. [Endopyelotomy for ureteropelvic junction obstruction: results and complications].
Baba Y; Takai K; Nakamura K; Kurisu H; Kamada K; Ishizu K; Takihara H; Naito K; Hayashida H; Yasui H
Hinyokika Kiyo; 1994 Jan; 40(1):15-8; discussion 18-9. PubMed ID: 8109469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
